TG Therapeutics stockTGTX
TG Therapeutics trades at $57.98, 8.8% below its 52-week high (Nov 2, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +94.5% year to date, +70.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for TGTX — after you log in
Open the terminalFrequently asked questions about TG Therapeutics
What is the TG Therapeutics stock price?
At the close on Nov 5, 2026: $57.98 (−5.92% on the day). 52-week high: $63.60 on Nov 2, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does TG Therapeutics report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −71% year over year, revenue +70%.
Does TG Therapeutics pay dividends?
No, TG Therapeutics does not pay dividends.
Where does TG Therapeutics trade and how to buy it?
Ticker TGTX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy TG Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for TGTX are in the terminal after you log in.